As part of a series of posts on the state of kinase inhibitors in formal clinical development, above is a mapping of the kinases for which there are potential drugs in trials. The figure was prepared by our collaborators Prson Gautam and Krister Winnerberg at FIMM, from the data in ChEMBL.
